France In-Vitro Diagnostics Market By Segments, Companies, Forecast by 2026
France In-Vitro Diagnostics market is expected to reach US$ 2.1 Billion by 2026. Forecast By Segments, Types, Company Overview, Initiatives & Recent Developments, Sales Analysis.
By: Renub Research
Another important IVD market in France is that the country's private medical analysis laboratories merge into larger units. Usually, several private laboratories join together as a Sociétésd' Exercise Liberal (liberal exercise company) known in France as an SEL. Within an SEL, each laboratory specializes in a specific type of analysis. Besides, the consolidating and regrouping of laboratories also lead to a rapidly shrinking number of biologists and laboratories, especially private laboratories, in the past few years. However, these changes are complex at first but could make the market more efficient in the long run. The France IVD Market Size was valued at US$ 1.9 Billion in 2020.
In the France IVD market segments, significant growth has happened in the Infectious Immunology segment in the year 2020. Other segments, Hematology, Immunochemistry, Microbiology, Bio-chemistry and Genetic Testing have a slight decline for one year. But all these segments are expected to keep on growing in the long run. Clinical chemistry plays a crucial role in the France IVD market. The market for reagents has continued to grow in the past few years. The French IVD Industry is expected to increase marginally at a CAGR of 1.68% during 2020-2026.
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-
Phone No: +1 678-302-0700 (USA) | +91–120–421–
Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/